Sirtex Medical Limited CEO takes leave as it investigates share selling

Sirtex Medical Limited (ASX:SRX) CEO, Gilman Wong, has taken temporary leave as the company investigates his recent share sale.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After a week of shareholder backlash and media scrutiny, Sirtex Medical Limited (ASX:SRX) CEO, Gilman Wong, has taken temporary leave as the company investigates his recent share selling.

After forecasting "double digit" dose sales for its 2017 financial year on October 25, Sirtex CEO Gilman Wong took to the market to sell shares in his own company on October 27. All up he sold just under 75,000 shares, worth around $2.13 million. According to his statement to the ASX, Mr Wong still holds 200,000 shares with performance rights on another 118,930.

On November 7, the company issued a statement providing a reason for Mr Wong's share sale. In the statement Mr Wong said, "To clarify, the reason for the sale of shares was to cover the tax incurred in relation to the recently vested tranche of rights."

Then, on December 9, the company issued a trading update forecasting 5% to 11% growth in full year dose sales and a fall in operating profit over the prior year.

On December 15, the ASX sent Sirtex a 'please explain' letter, following a "tip-off" in order to better understand the change in growth forecasts. Sirtex told the ASX, "As you are aware, SRX's business has a very short sales cycle, measured in days. As a result, there is no transparency on dose sales beyond a very short window."

CEO to take leave

Throughout this saga, the company was the subject of a significant amount of shareholder and media scrutiny, with its share price falling 38% since December 8. Indeed, shareholders are left questioning the timing of the CEO's share sale. Was it simply luck or something else?

On Friday night, the company announced it has engaged legal advisors Watson Mangioni to investigate the share trading of Mr Wong.

"Mr Wong denies any wrong-doing concerning his share trading, but, in the interests of due process, and in the best interests of the Company, he has volunteered to take temporary leave across the New Year period, until the investigation has been completed."

"The Sirtex Board wishes to emphasise that its decision to commission this investigation has been made solely for the purpose of ensuring that the concerns raised with the Company are appropriately investigated, and in no way implies any wrongdoing on the part of Mr Wong."

Foolish takeaway

As my colleague, Tom Richardson, wrote last week, the market was shocked by Sirtex's announcement on December 9. It seems investors were expecting the good times to continue. 

Given the uncertainty surrounding the business' growth outlook and management, I suggest investors steer clear of Sirtex shares for the time being.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »